However, contrary to the changes in MDM2 gene and protein expression in WPMY-1 cells, our research group found in previous studies that BPH-1 cells exhibited up-regulated MDM2 gene and protein expression after Cu B treatment [18]. The gene discussed is MDM2; the disease is benign prostatic hyperplasia.